HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clindamycin in treatment of aspiration pneumonia in children.

Abstract
Twenty-eight patients with anaerobic pleuropulmonary infections were treated with clindamycin alone or clindamycin with gentamicin. Sixteen of the patients presented with pneumonitis, nine with necrotizing pneumonia, and three with lung abscesses. The average length of treatment was 13.8 days, and the duration of temperature after initiation of therapy was 3.1 days. The predominant isolates were anaerobic gram-positive cocci (23 isolates), Bacteroides melaninogenicus (14), Bacteroides fragilis (9), and Fusobacterium nucleatum (11). The most frequent aerobic isolates were alpha-hemolytic streptococci (12), Diplococcus pneumoniae (12), Pseudomonas aeruginosa (9), Klebsiella pneumoniae (7), group A beta-hemolytic streptococci (5), Staphylococcus aureus (9), and Escherichia coli (6). All patients responded to the therapy and were cured of the infection. There were no side effects observed from the administration of clindamycin. None of the patients developed any blood dyscrasia, liver damage, diarrhea, or colitis. Clindamycin appears to be effective in the treatment of mixed aerobic and anaerobic pleuropulmonary infections in children, alone or with an aminoglycoside when indicated.
AuthorsI Brook
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 15 Issue 3 Pg. 342-5 (Mar 1979) ISSN: 0066-4804 [Print] United States
PMID380459 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Gentamicins
  • Clindamycin
Topics
  • Adolescent
  • Anaerobiosis
  • Child
  • Child, Preschool
  • Clindamycin (therapeutic use)
  • Clinical Trials as Topic
  • Female
  • Gentamicins (therapeutic use)
  • Humans
  • Infant
  • Male
  • Pneumonia, Aspiration (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: